TREATMENT ISSUES, Volume 6, Number 8 - September, 1992; The Gay Men's Health Crisis Newsletter of Experimental Therapies
Gabriel Torres, M.D.
Another researcher, Dr. Sudhir Gupta from the University of California at Irvine reported evidence of a new virus in a 66 year old woman who had developed severe immunodeficiency and OIs many years after receiving blood transfusions. Dr. Gupta described the virus as a "human intracisternal retroviral particle" or "HICVR" because it was found in closed spaces called cisterns in the cytoplasm of cells. Other researchers countered that these particles represented lab contaminants and not viruses. Dr. Max Essex of Harvard's School of Public Health argued that this virus-like particle was probably a "retroid"--a fragment of the normal human gene that resembles a virus, yet which have no pathogenic potential. In this case, as in four of Dr. Ho's cases, reverse transcriptase (the enzyme that copies HIV inside infected cells) was present. However, this is a non-specific finding that occurs during Hepatitis C, Grave's disease, and Kawasaki's disease.
Other researchers from New York reported cases of Kaposi's sarcoma (KS) in gay men who were not infected with HIV. Most of these cases were relatively mild (non-extensive, less than 10 lesions and without oral involvement) and their meant T4 cell count was 768. Tumor samples failed to show HIV-1 OI HIV-2, but one patient's tumor revealed evidence of HTLV-1. It has been postulated that an undetermined sexually transmitted agent may be responsible for the development of KS in these men. Officials from the World Health Organization and the CDC plan to organize an international meeting to investigate all these cases of HIV negative AIDS from both a basic science and an epidemiological perspective. In the meantime, The New York City Department of Health is gathering information about any immune suppressed illness that may be related to these cases. Doctors, health care providers, people with HIV and others are encouraged to contact Allen Greenberg at (212) 566-5062, who is conducting investigations.
Copyright (c) 1992. Treatment issues is published ten times yearly. All rights reserved. Non-commercial reproduction is encouraged. Distributed by AEGIS, your online gateway to a world of people, knowledge, and resources. Direct Dial: v.34+: 714.248.2836; v.120/ISDN: 714.248.0433 Internet: telnet:aegis.com www: www.aegis.com
9209
GM060803
Copyright © 1992 - Treatment Issues. Reproduced with permission. Treatment Issues is published twelve times yearly by GMHC, Inc. All rights reserved. Noncommercial reproduction is encouraged. Subscription lists are kept confidential. GMHC Treatment Issues, The Tisch Building, 119 West 24th Street, New York, NY 10011 fredg@gmhc.org http://www.gmhc.org
AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, iMetrikus, Inc., John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .